Winton Group LTD United Therapeutics Corp Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$214.88 - $256.94 $165,457 - $197,843	-770 Reduced 42.66%	1,035 $227,000
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $65,452 - $76,706	309 Added 20.66%	1,805 $407,000
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $2.05 Million - $2.32 Million	-9,967 Reduced 86.95%	1,496 $330,000
Q1 2023 May 12, 2023	SELL	$212.99 - $276.17 $379,974 - $492,687	-1,784 Reduced 13.47%	11,463 $2.57 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $1.16 Million - $1.58 Million	-5,645 Reduced 29.88%	13,247 $3.68 Million
Q3 2022 Nov 10, 2022	BUY	$203.3 - $244.17 $166,096 - $199,486	817 Added 4.52%	18,892 $3.96 Million
Q2 2022 Aug 10, 2022	BUY	$174.81 - $241.14 $362,031 - $499,400	2,071 Added 12.94%	18,075 $4.26 Million
Q1 2022 May 11, 2022	BUY	$166.16 - $213.96 $937,308 - $1.21 Million	5,641 Added 54.43%	16,004 $2.87 Million
Q4 2021 Feb 10, 2022	BUY	$184.32 - $216.08 $352,051 - $412,712	1,910 Added 22.6%	10,363 $2.24 Million
Q3 2021 Oct 28, 2021	SELL	$179.86 - $214.88 $343,712 - $410,635	-1,911 Reduced 18.44%	8,453 $1.56 Million
Q2 2021 Aug 10, 2021	SELL	$170.47 - $211.93 $507,148 - $630,491	-2,975 Reduced 22.3%	10,364 $1.86 Million
Q1 2021 Jul 21, 2021	SELL	$153.94 - $174.85 $126,538 - $143,726	-822 Reduced 5.8%	13,339 $2.23 Million
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $2.48 Million - $3.7 Million	-24,380 Reduced 63.26%	14,161 $2.15 Million
Q3 2020 Oct 30, 2020	SELL	$99.9 - $121.13 $1.73 Million - $2.1 Million	-17,331 Reduced 31.02%	38,541 $3.89 Million
Q2 2020 Aug 05, 2020	BUY	$92.74 - $125.82 $4.89 Million - $6.64 Million	52,752 Added 1690.77%	55,872 $6.76 Million
Q1 2020 May 11, 2020	BUY	$79.39 - $115.35 $247,696 - $359,892	3,120 New	3,120 $296,000
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $21.2 Million - $25.9 Million	-271,159 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$74.85 - $85.99 $5.92 Million - $6.8 Million	79,084 Added 41.17%	271,159 $21.6 Million
Q2 2019 Jul 08, 2019	BUY	$76.06 - $120.81 $1.41 Million - $2.24 Million	18,559 Added 10.7%	192,075 $15 Million
Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $1.61 Million - $1.9 Million	15,000 Added 9.46%	173,516 $20.4 Million
Q4 2018 Feb 05, 2019	BUY	$101.4 - $128.73 $6.72 Million - $8.53 Million	66,257 Added 71.82%	158,516 $17.3 Million
Q3 2018 Nov 02, 2018	BUY	$113.81 - $129.46 $6.69 Million - $7.61 Million	58,814 Added 175.85%	92,259 $0
Q2 2018 Aug 20, 2018	BUY	$101.14 - $118.31 $3.38 Million - $3.96 Million	33,445 New	33,445 $0
Q1 2018 May 21, 2018	SELL	$107.21 - $151.94 $2.05 Million - $2.9 Million	-19,091 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$118.58 - $151.28 $2.26 Million - $2.89 Million	19,091 New	19,091 $2.83 Million
Q3 2017 Nov 13, 2017	SELL	$114.6 - $136.81 $7.53 Million - $8.99 Million	-65,741 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	65,741	65,741 $8.53 Million

Others Institutions Holding UTHR

# of Institutions

679

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.06 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$830 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account